OrsoBio has announced the publication in Nature Medicine of Phase I clinical trial data for TLC-2716, an oral liver-targeted ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

Preclinical and Phase 1 study published in Nature Medicine describes clinical and mechanistic validation for OrsoBio's LXR ...

A selective Liver X Receptor inverse agonist lowered triglycerides and post-meal cholesterol in people, opening a safer path to treat hypertriglyceridemia.

MENLO PARK, Calif.--(BUSINESS WIRE)--OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, today announced new data for ...

Nature’s biomolecules are classified into four major groups: Carbohydrates, Proteins, Nucleic Acids, and Lipids. Of these four, the lipid designation includes the most diverse and complex group, ...

PALO ALTO, Calif.--(BUSINESS WIRE)--OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced its acquisition of assets relating ...

Asharq Al Awsat A study led by researchers from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, revealed ...